کد مقاله | کد نشریه | سال انتشار | مقاله انگلیسی | نسخه تمام متن |
---|---|---|---|---|
1225960 | 968264 | 2012 | 9 صفحه PDF | دانلود رایگان |
Diabetic retinopathy is the leading cause of new cases of legal blindness among adults in the developed countries. Approximately 40% of all people with diabetes have diabetic retinopathy and 5% of these have sight-threatening form. As the advanced stage, where there is a high risk for vision loss, can develop without any serious symptoms, sometimes it is hard to detect it. A non invasive method to detect biomarkers characteristic for diabetic retinopathy from the tear fluid was developed. Tear samples from diabetic patients with no retinopathy, non proliferative and proliferative stages of diabetic retinopathy were analyzed and the protein content of each sample was compared to the protein content of tear pool from healthy volunteers. The samples were labeled with iTRAQ fourplex labels and were analyzed with nanoHPLC coupled ESI-MS/MS mass spectrometry. The lipocalin 1, lactotransferrin, lacritin, lysozyme C, lipophilin A and immunoglobulin lambda chain were identified as possible biomarker candidates with significantly higher relative levels in the tear of patients with diabetic retinopathy.
Figure optionsDownload high-quality image (90 K)Download as PowerPoint slideHighlights
► Tear proteome of patients with diabetic retinopathy was analyzed.
► The protein content of tear samples decreased with the progression of the disease.
► The relative abundance of some of the proteins increased significantly.
► These proteins were proposed as biomarkers for diabetic retinopathy.
Journal: Journal of Proteomics - Volume 75, Issue 7, 3 April 2012, Pages 2196–2204